Evan Siegel is a Rheumatology/Immunology physician. OpenAlex indexes 34 publications with 3,754 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
14995 Shady Grove Rd Ste 500
Rockville, MD 208508726
Telephone
301-942-7600Provider last certified this registry record 17 Feb 2026.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year202545 payments$47,921openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202519 payments$21,087openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year202521 payments$18,131openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
51%Other drugs affecting bone structure and mineralization25.5%Romosozumab-aqqg100%Part B, office-administered≥40 patientsRANK Ligand Inhibitor24.8%Denosumab100%Part B, office-administered≥235 patients+ 6 more classes in this area
Cancer & immunology
45%Interleukin-6 Receptor Antagonist30.1%Tocilizumab100%Part B, office-administered≥15 patientsTNF inhibitor14.4%Golimumab83%Infliximab17%Humira(Cf) Pen0%Enbrel Sureclick0%Part D + Part B<11 patients+ 6 more classes in this area
Dermatology
3.3%Corticosteroid3.3%Methylprednisolone acetate97%Triamcinolone acetonide2%Methylprednisolone1%Part D + Part B≥52 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- What Matters in Psoriatic Arthritis: A Comparison of Patient and Clinician Perspectives
ACR Open Rheumatology
2025 - Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”